Clinical trial data requires the highest standard of integrity, security, and auditability. Here's how Clinly's architecture delivers on that.
Honest about where we are today and where we're heading.
Designed and built toward 21 CFR Part 11 alignment. Append-only audit trails, role-based access controls, and electronic record integrity are built into the data layer. Formal IQ/OQ/PQ validation is a funded milestone.
Formal IQ/OQ/PQ validation documentation: planned Q3 2026 (funded via seed round).
Clinly's data architecture follows HIPAA technical safeguard principles: encryption at rest and in transit, access controls, audit controls, and data integrity measures.
Formal BAA and HIPAA attestation: planned with first enterprise customer onboarding.
SOC 2 Type II audit is on the roadmap and will be completed after the seed round closes. Controls are being designed to the SOC 2 framework now.
We do not currently hold SOC 2 Type II certification. We will be transparent about this with all prospects.
Enterprise risk mitigation: Clinly is designed for pilots to run on de-identified or synthetic data until formal IQ/OQ/PQ validation is complete. First CRO partners receive a dedicated deployment environment with no shared-tenant data exposure.
Security due diligence package (architecture diagrams, data flow maps, audit trail documentation) available on request. Request package →
Every data change in Clinly generates an append-only audit record before it touches the main table. This is not a log file — it's enforced at the database trigger level.
User ID and session token captured on every operation. Linked to the authenticated user account.
UTC timestamp with millisecond precision. Server-side clock — not client-supplied.
Complete before/after JSON snapshot. Every field value before and after the change is stored.
FDA Electronic Records and Electronic Signatures. Audit trail, access controls, record integrity — all implemented at the database layer.
Clinical Data Acquisition Standards Harmonization. Form templates and variable mappings follow CDASH standards for FDA and EMA submissions.
Operational Data Model XML 1.3.2. Full ODM-XML export for regulatory submissions to FDA and EMA.
Good Clinical Practice guidelines. Audit trail, source data verification support, and data integrity controls align with ICH E6(R2) requirements.
European Medicines Agency guidance for computerised systems in clinical trials. Controls are being mapped to Annex 11 requirements.
Trust Services Criteria: Security and Availability. Formal audit planned for Q1 2027 post-seed funding. Controls are being documented now.
A direct comparison against the two platforms that dominate the regulated EDC market — Medidata Rave and Oracle InForm.
| Dimension | Medidata Rave | Oracle InForm | Clinly |
|---|---|---|---|
| Setup Time | 12–16 weeks | 8–12 weeks | 7 days |
| Audit Trail | Application-layer logging; external validation required | Log-file based; complex configuration | PostgreSQL trigger-level; append-only architecture from day one |
| Protocol Parsing | Manual (CDM team, 4–6 wks) | Manual (specialist team required) | Automated extraction (87.8% accuracy, <60 sec) + HITL review |
| Cost per Trial | $200K–$400K+/yr | $150K–$300K+/yr | $15K–$25K setup + SaaS seats |
| Compliance Depth | 21 CFR §11 — requires separate IQ/OQ/PQ validation sprint | 21 CFR §11 — requires vendor validation package ($20K–$50K) | 21 CFR §11-aligned data layer — formal IQ/OQ/PQ validation is a funded seed milestone |
Legacy pricing estimated from published CRO benchmarks (Tufts CSDD, 2023). Clinly figures reflect current production pricing. Setup times reflect industry averages.
We're transparent about where we are and where we're heading. Reach out directly — we'll share our current security documentation.